Molbio Diagnostics IPO
ListedMainboardOpens 10 August 2026Closes 12 August 2026
Molbio Diagnostics Limited (incorporated in 2000 as Molbio Diagnostics Private Limited) is a point-of-care (POC) diagnostics company focused on delivering accurate, rapid, and cost-effective healthcare technologies for…
Molbio Diagnostics Limited (incorporated in 2000 as Molbio Diagnostics Private Limited) is a point-of-care (POC) diagnostics company focused on delivering accurate, rapid, and cost-effective healthcare technologies for infectious and non-communicable diseases. The company developed the 'Truenat' platform, a portable polymerase chain reaction (PCR) system that enables decentralized molecular testing for 30 diseases across 42 assays, patented in over 100 countries. Its Truenat TB test is WHO-endorsed for initial TB diagnosis and rifampicin resistance detection. The company operates five manufacturing facilities in Goa, Visakhapatnam, and Bengaluru, supplying products directly and via distributors to public health programs, laboratories, and hospitals across 80+ countries.
Show moreShow less
Key ratios
As per RHP / filingsTimeline
IPO Opens
10 Aug
IPO Closes
12 Aug
Allotment
13 Aug
Listing
17 Aug
IPO Timeline & Listing Details
| Event | Date |
|---|---|
| IPO Open Date | 10 August 2026 |
| IPO Close Date | 12 August 2026 |
| Allotment Date | 13 August 2026 |
| Listing Date | 17 August 2026 |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Retail (Min) | 1 | ₹14,526 |
Retail (Max)Just less than ₹2,00,000 | 13 | ₹1,88,838 |
SHNI (Min)Just above ₹2,00,000 | 14 | ₹2,03,364 |
SHNI (Max)Below ₹10,00,000 | 68 | ₹9,87,768 |
BHNIAbove ₹10,00,000 | 69 | ₹10,02,294 |
IPO Reservation Details
| Category | Reservation |
|---|---|
| QIB (Qualified Institutional Buyer) | 50.00% |
| NII (Non-Institutional Investor) | 15.00% |
| SHNI (Small Non-Institutional Investor) | 5.00% |
| BHNI (Big Non-Institutional Investor) | 10.00% |
| Retail | 35.00% |
| Total | 100.00% |
IPO Objectives
- Funding capital expenditure towards the setting up of infrastructure for research and development facility, Center of Excellence and connected office space (₹125.12 Cr).
- Funding capital expenditure towards the purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit (₹80.81 Cr).
- General Corporate Purposes.
Strengths
- Proprietary 'Truenat' portable PCR platform enabling rapid, point-of-care molecular testing for 30 diseases across 42 assays.
- WHO-endorsed Truenat TB test for initial Tuberculosis diagnosis and rifampicin resistance detection.
- Global footprint spanning 80+ countries supported by 5 manufacturing units in Goa, Visakhapatnam, and Bengaluru.
- Recurring revenue streams from proprietary test kits alongside capital device sales.
Weaknesses
- High revenue dependence on public health programs, central/state governments, and international aid agencies.
- Significant product concentration risk tied to test kits for Tuberculosis.
- Substantial capital and time requirements for R&D and obtaining global regulatory approvals for new assays.
- Exposure to supply chain disruptions for electronic components, reagents, and specialized raw materials.
Financial Performance
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets (₹ Cr.) | 2,148.42 | 1,461.56 | 1,221.06 |
| Revenue (₹ Cr.) | 1,455.17 | 1,027.94 | 840.66 |
| PAT (₹ Cr.) | 164.14 | 138.58 | 83.54 |
| Net Worth (₹ Cr.) | 1,144.68 | 952.95 | 807.94 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|---|---|---|---|
| Molbio Diagnostics | 7.95 | 55.43 | 15.59% | 1,144.68 |
| Vijaya Diagnostic Centre | 14.7 | 81.35 | 18.07% | 77.53 |
| Metropolis Healthcare | 7.77 | 57.52 | 12.56% | 72.46 |
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 1x | 1.39x | 186.39x |
| NII | 0.73x | 4.46x | 49.8x |
| S-HNI | 0.8x | 7.02x | 47.76x |
| B-HNI | 0.7x | 4.31x | 50.82x |
| RII | 0.77x | 3.19x | 12.97x |
| EMP | 2.12x | 4.79x | 13.28x |
| Total | 0.83x | 2.95x | 70.27x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 23,25,146 | 43,33,82,148 | 34,973.94 |
| NII | 17,43,859 | 8,68,40,604 | 7,008.04 |
| Small NII | 5,81,286 | 2,77,64,010 | 2,240.56 |
| Big NII | 11,62,573 | 5,90,76,594 | 4,767.48 |
| RII | 40,69,004 | 5,27,67,810 | 4,258.36 |
| EMP | 20,520 | 2,72,466 | 21.99 |
| Total | 81,58,529 | 57,32,63,028 | 46,262.33 |
Company Details
- Molbio Diagnostics Limited
- Plot No. L-46, Phase II-D, Verna Industrial Area, Verna, Salcete, South Goa 403 722, Goa, India
- +91 832 6724888
- investors@molbiodiagnostics.com
- https://www.molbiodiagnostics.com/
Registrar Details
- KFin Technologies Limited
- +91 40 6716 2222
- molbio.ipo@kfintech.com
- https://www.kfintech.com/
Frequently Asked Questions
What does Molbio Diagnostics Limited do?
What are the IPO dates for Molbio Diagnostics IPO?
What is the price band and minimum investment for Molbio Diagnostics IPO?
What is the issue size of Molbio Diagnostics IPO?
What is the Molbio Diagnostics IPO listing date?
Molbio Diagnostics IPO News & Updates
Follow the latest updates for Molbio Diagnostics IPO, including grey market moves and allotment news.
Molbio Diagnostics IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Molbio Diagnostics IPO Details
Issue size, price, financials, and company info
Molbio Diagnostics IPO GMP
Live grey market premium and listing estimate
Molbio Diagnostics IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Molbio Diagnostics IPO Allotment
Allotment date, chances, and check by PAN
Molbio Diagnostics IPO Review
SWOT, strengths, risks, and IPO review
Molbio Diagnostics IPO FAQ
Common questions on dates, GMP, and allotment
Molbio Diagnostics IPO Registrar
Registrar website and how to check allotment
Molbio Diagnostics IPO Timeline
Open, close, allotment, and listing dates
Molbio Diagnostics IPO News
Updates, blogs, and latest IPO news
Sources
We match Molbio Diagnostics IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- KFin Technologies LimitedOfficial site to check allotment status for this IPO
Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.